Search research articles
Contact Us
Filters
Showing results (411-420 of 420) with videos related to
Page
of 42
Sort By:
You have reached the last page of results.
This site can display upto 420 results.
The Journal of Antimicrobial Chemotherapy
|
September 1, 1985
Cefpiramide: comparative in-vitro activity and beta-lactamase stability
A L Barry, R N Jones, C Thornsberry, et al.
Journal of Clinical Microbiology
|
September 1, 1993
Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters
A L Barry, P C Fuchs, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 1, 1993
Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine
A L Barry, M A Pfaller, P C Fuchs, et al.
The Journal of Infectious Diseases
|
October 1, 1976
Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae
A L Barry, F D Schoenknecht, R Norton, et al.
Journal of Clinical Microbiology
|
January 1, 1989
Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria
R J Zabransky, D G Bobey, A L Barry, et al.
Journal of Clinical Microbiology
|
September 1, 1984
Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories
R N Jones, C Thornsberry, A L Barry, et al.
Journal of Clinical Microbiology
|
July 1, 1981
Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study
T L Gavan, R N Jones, A L Barry, et al.
Journal of Clinical Microbiology
|
September 2, 2000
Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
A L Barry, M A Pfaller, S D Brown, et al.
Reviews of Infectious Diseases
|
January 1, 1990
Multilaboratory evaluation of an agar diffusion disk susceptibility test for rapidly growing anaerobic bacteria
A L Barry, P C Fuchs, E H Gerlach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1997
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards
J H Rex, M A Pfaller, J N Galgiani, et al.
Page
of 42
Search research articles
Search
Showing results (411-420 of 420) with videos related to
Sort By:
Page
of 42
You have reached the last page of results.
This site can display upto 420 results.
The Journal of Antimicrobial Chemotherapy
|
September 1, 1985
Cefpiramide: comparative in-vitro activity and beta-lactamase stability
A L Barry, R N Jones, C Thornsberry, et al.
Journal of Clinical Microbiology
|
September 1, 1993
Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters
A L Barry, P C Fuchs, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 1, 1993
Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine
A L Barry, M A Pfaller, P C Fuchs, et al.
The Journal of Infectious Diseases
|
October 1, 1976
Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae
A L Barry, F D Schoenknecht, R Norton, et al.
Journal of Clinical Microbiology
|
January 1, 1989
Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria
R J Zabransky, D G Bobey, A L Barry, et al.
Journal of Clinical Microbiology
|
September 1, 1984
Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories
R N Jones, C Thornsberry, A L Barry, et al.
Journal of Clinical Microbiology
|
July 1, 1981
Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study
T L Gavan, R N Jones, A L Barry, et al.
Journal of Clinical Microbiology
|
September 2, 2000
Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
A L Barry, M A Pfaller, S D Brown, et al.
Reviews of Infectious Diseases
|
January 1, 1990
Multilaboratory evaluation of an agar diffusion disk susceptibility test for rapidly growing anaerobic bacteria
A L Barry, P C Fuchs, E H Gerlach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1997
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards
J H Rex, M A Pfaller, J N Galgiani, et al.
Page
of 42